With fall approaching and COVID-19 activity rising across the country, confusion over vaccines is widespread. Mixed messages ...

The only two approved treatments for Alzheimer’s that can slow progression—developed by Eli Lilly and Biogen-Eisai—work by removing amyloid plaque. They reduce cognitive dec ...

Boehringer Ingelheim's bid to return to the oncology arena has been achieved with an FDA approval for Hernexeos, a new, ...

Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration vaccine regulator Vinay Prasad will return to the agency.

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

Prasad resigned from the FDA in July after backlash over his handling of Sarepta’s Elevidys gene therapy, which faced ...

I don’t know what we’re supposed to do,” said Aaron Hardwick, who tested positive for COVID-19 in June. “Can we get the shot?

President Donald Trump announced that he's nominating State Department spokesperson Tammy Bruce to be the next deputy representative of the United States to the United Nations.

T O APPRECIATE the dilemmas the Food and Drug Administration (FDA) faces when it reviews new drugs targeting rare diseases, ...

Dr. Vinay Prasad is back at the FDA less than two weeks after the White House pressed the head of the agency to remove him from his multiple agency leadership roles, an HHS spokesperson said Saturday.

The public deserves to the full story about Dr. Vinay Prasad's temporary resignation and how this might impact regulatory decisions moving forward.

A top Food and Drug Administration official is getting his job back, a spokesman for health agencies said Saturday, less than two weeks after he was ousted at the direction of the White House. Vinay ...